Applied Biosystems/MDS Analytical Technologies AB SCIEX QTRAP 5500 Mass Spectrometry System Earns Scientists’ Choice Award from SelectScience

CARLSBAD, Calif.--(BUSINESS WIRE)--Applied Biosystems, a division of Life Technologies (NASDAQ:LIFE), and its mass spectrometry joint-venture partner, MDS Analytical Technologies, a business unit of MDS Inc. (TSX:MDS) (NYSE:MDZ), today announced that the AB SCIEX QTRAP^® 5500 System, a unique, next-generation mass spectrometer, has received the Scientists’ Choice Award for Best New Spectroscopy Product by SelectScience.net, a leading online resource for applied chemists, clinical chemists and life scientists. This award was based on the results of an independent poll of more than 25,000 scientists, who were asked to nominate and vote for their favorite new spectroscopy products.

“SelectScience is honored to present Applied Biosystems/MDS Analytical Technologies with the Scientists’ Choice Award for Best New Spectroscopy Product of 2008”

The AB SCIEX QTRAP 5500 System is the only system on the market that combines qualitative and quantitative analysis capabilities in a single system. This uniquely enables scientists to identify and confirm a greater number of compounds, proteins and contaminants in a single analysis, rather than having to utilize two different technologies to achieve the same results. This system was developed as a powerful tool for the increasing number of scientists who are adopting mass spectrometry for a wide variety of laboratory applications, such as drug discovery, food testing, environmental analysis and the study of diseases.

“SelectScience is honored to present Applied Biosystems/MDS Analytical Technologies with the Scientists’ Choice Award for Best New Spectroscopy Product of 2008,” said Kerry Parker, Editor of SelectScience.net. “This new system clearly has captured the imagination of the scientific community as evidenced by its tremendous popularity in such a brief period on the market. The Scientists’ Choice Award provides a unique channel for the online community to voice opinions, and provide feedback to manufacturers, about which new products have significantly contributed towards laboratory research efforts.”

The AB SCIEX 5500 System, which was launched in October of last year, is the newest addition to the comprehensive portfolio of industry-leading LC/MS/MS mass spectrometry systems, software and workflow applications from Applied Biosystems/MDS Analytical Technologies. For qualitative analysis, this system features a new innovation in ion trap technology known as Linear Accelerator™ Trap, which is combined with industry-leading triple quadrupole capabilities used for quantitative analysis to create an innovative, one-of-a-kind system.

“Scientists are seeking best-in-class mass spectrometry solutions to help drive new discoveries and improve health and safety,” said Laura Lauman, President of Life Technologies’ Mass Spectrometry Systems Division. “The Scientists’ Choice Award for the AB SCIEX QTRAP 5500 System confirms that we have once again set a new standard for mass spectrometry instruments and that the scientific community is quickly embracing this unique technology.”

Andy Boorn, President of MDS Analytical Technologies, which developed the award-winning instrument, added: “The AB SCIEX QTRAP 5500 System is one of the most advanced mass spectrometry systems ever built. We designed it based upon feedback from the scientific community regarding what they needed a next-generation mass spectrometry platform to achieve; therefore, this award validates our approach to developing breakthrough technologies that are truly differentiated from other available systems.”

Applied Biosystems is a global leader in providing innovative instrument systems to accelerate academic and clinical research, drug discovery and development, pathogen detection and forensic DNA analysis. It is a leading provider of mass spectrometry solutions through its joint venture with MDS Analytical Technologies. Applied Biosystems, along with Invitrogen – a leading provider of platform independent, essential life science technologies for disease and drug research, bioproduction and diagnostics – is part of Life Technologies. Applied Biosystems and Invitrogen products are used in nearly every major laboratory in the world.

For more information, please visit: www.appliedbiosystems.com and www.invitrogen.com.

About Life Technologies

Life Technologies Corporation (NASDAQ:LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of more than $3 billion in 2008, employs approximately 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of approximately 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc. For more information on how we are making a difference please visit our website: www.lifetechnologies.com.

About MDS Analytical Technologies

MDS Analytical Technologies, a business unit of MDS Inc. (TSX:MDS) (NYSE:MDZ), is focused on the research, design, manufacture and marketing of state-of-the-art tools for mass-spectrometry, drug discovery and bioresearch. MDS Analytical Technologies’ products are designed to help accelerate the complex process of discovering and developing new drug compounds, and are sold to research scientists around the world. The mass-spectrometer product lines are also sold globally through joint ventures with two of the world’s leading analytical instrumentation and life-sciences companies, Life Technologies Corporation and PerkinElmer, Inc. Find out more at www.mdssciex.com or www.moleculardevices.com.

Safe Harbor Statement

This press release includes forward-looking statements about our anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies’ plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect” and the like, and/or future tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.

Copyright 2009. Life Technologies Corporation. All rights reserved. Linear Accelerator is a trademark and QTRAP is a registered trademark of Applied Biosystems/MDS Analytical Technologies, a joint venture between Life Technologies and MDS Inc.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5920001&lang=en